Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | Director · CHAIRMAN, CEO | August 15, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 511,095.7173 |
Reported balance
After 2026-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-15 · Tax withholding · Disposed 12,350 · Balance 511,095.7173 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust with Wife | 345,861 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 345,861 F3: Shares held in trust with Mr. Lipps' wife. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust for Children | 8,051 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 8,051 F4: Shares held in trust for the benefit of Mr. Lipps' children. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26.
F3: Shares held in trust with Mr. Lipps' wife.
F4: Shares held in trust for the benefit of Mr. Lipps' children.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-23 · Disposition to issuer · Disposed 63,452 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2018-10-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-10-23 · Disposition to issuer · Disposed 7,722 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-07-26 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-23 · Disposition to issuer · Disposed 2,054 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager.
F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2026 Filed Aug 18, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 12,350 | $37.30 | $460,655.00 |
DisclosureSEC source: 0001227556-26-000012 · form4-08182026_040809.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,095.7173 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2 · balance_after: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 10,000 | $47.00 | $470,000.00 |
DisclosureSEC source: 0001227556-26-000010 · form4-07172026_040701.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, CEO 10b5-1 filing: Plan reported Ownership: Indirect · In Trust with Wife Disclosed balance after: 345,861 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2026. F2 · price: The price reported in Column 4 is an exact price of $47.00 for all shares sold. F3 · balance_after: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 12,347 | $43.12 | $532,402.64 |
DisclosureSEC source: 0001227556-26-000008 · form4-05192026_050515.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,184.0741 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 90,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001227556-26-000006 · form4-04032026_040402.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 535,531.0741 F3 · shares: Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 15,642 | $34.40 | $538,084.80 |
DisclosureSEC source: 0001227556-26-000004 · form4-03172026_040301.xml · nonDerivative · entry 2 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,592.0741 F2 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 79,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001227556-26-000004 · form4-03172026_040301.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,234.0741 F1 · shares: Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 79,494 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 5,294 | $36.50 | $193,231.00 |
DisclosureSEC source: 0001227556-26-000002 · form4-02182026_040201.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,740.0741 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2 · balance_after: The balance is adjusted to reflect .4503 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/2025 and 532.6238 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/2026. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,147 | $43.27 | $49,630.69 |
DisclosureSEC source: 0001227556-25-000009 · form4-12172025_041205.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,501 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 28,250 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001227556-25-000007 · form4-12032025_041211.xml · derivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,250 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. F5 · derivative.exercise_date: The options were granted on 2/4/2016 with 25% vested on the one-year anniversary of the grant date and the reaming amount vesting ratably over a 36 month period. The options were fully vested on 2/4/2020. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 28,250 | $35.97 | $1,016,093.18 |
DisclosureSEC source: 0001227556-25-000007 · form4-12032025_041211.xml · nonDerivative · entry 2 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 386,648 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. F2 · price: The price reported in Column 4 is a weighted average price of $35.9679. The sold price range between $35.65 to $36.4746. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 28,250 | $27.70 | $782,525.00 |
DisclosureSEC source: 0001227556-25-000007 · form4-12032025_041211.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 414,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:22 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,437 | $35.12 | $296,307.44 |
DisclosureSEC source: 0001227556-25-000004 · form4-11182025_091118.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,648 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:15 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,438 | $31.69 | $267,400.22 |
DisclosureSEC source: 0001415889-25-022302 · form4-08192025_080847.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,085 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 21:27 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,146 | $29.25 | $33,520.50 |
DisclosureSEC source: 0001415889-25-017574 · form4-06172025_090653.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,523 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:04 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,435 | $28.08 | $236,854.80 |
DisclosureSEC source: 0001415889-25-013607 · form4-05192025_080511.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,669 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:13 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 79,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008372 · form4-03182025_080321.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,104 F4 · shares: Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:13 UTC | OMNICELL, INC. OMCL · Entity 4666 | PurchaseCommon Stock | 10,561 | $33.13 | $349,874.31 |
DisclosureSEC source: 0001415889-25-008372 · form4-03182025_080321.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,610 F3 · price: The price reported in Column 4 is a weighted average price of $33.1289 The purchase price range between $32.745 to $33.44 The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 20:25 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 18,571 | $36.99 | $686,941.29 |
DisclosureSEC source: 0001415889-25-007663 · form4-03112025_080326.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,049 F4 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 20:25 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 188,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007663 · form4-03112025_080326.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,620 F3 · shares: Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 188,794 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:04 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 6,652 | $38.06 | $253,175.12 |
DisclosureSEC source: 0001415889-25-006458 · form4-03042025_090352.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,826 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| February 15, 2025 Filed Feb 18, 2025 21:10 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 756 | $39.61 | $29,945.16 |
DisclosureSEC source: 0001415889-25-004393 · form4-02182025_090237.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,478 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F4 · balance_after: The balance is adjusted to reflect 875 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/25. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 22:41 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,202 | $46.01 | $193,334.02 |
DisclosureSEC source: 0001415889-24-029641 · form4-12172024_101211.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,359 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,155 | $45.67 | $52,748.85 |
DisclosureSEC source: 0001415889-24-027193 · form4-11192024_091114.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,561 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:04 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 6,043 | $42.93 | $259,425.99 |
DisclosureSEC source: 0001415889-24-021552 · form4-08192024_080855.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,716 F4 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2 · balance_after: 37,093 Shares transferred from directly owned account to Family Trust Account on 8-8-2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 19:01 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,599 | $27.91 | $72,538.09 |
DisclosureSEC source: 0001415889-24-017359 · form4-06182024_070603.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,852 F3 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 107,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005877 · form4-02292024_090218.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,451 F3 · shares: Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 1, 2025. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15. F4 · balance_after: The balance is adjusted to reflect 459 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/24. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 6,433 | $38.26 | $246,126.58 |
DisclosureSEC source: 0001415889-23-016578 · form4-12182023_091247.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,741 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2 · balance_after: The balance is adjusted to reflect 1 share purchased under the Issuer's Employee Stock Purchase Plan on 8/15/23. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 5,028 | $72.32 | $363,624.96 |
DisclosureSEC source: 0001415889-23-009930 · form4-06162023_080627.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,173 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | PurchaseCommon Stock | 4,000 | $73.76 | $295,040.00 |
DisclosureSEC source: 0001415889-23-009620 · form4-06122023_080624.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Indirect · In Trust with Wife Disclosed balance after: 318,768 F1 · price: The price reported in Column 4 is a weighted average price of $73.76. The purchase price ranges between $73.4250 to $74.2050. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:44 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 47,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009119 · form4-06022023_080648.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,201 F1 · shares: Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on February 15, 2024. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15. F2 · balance_after: 12,719 shares transferred from directly owned account to Family Trust Account on 3/1/23. F3 · balance_after: The balance is adjusted to reflect 224 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:04 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,652 | $48.44 | $419,102.88 |
DisclosureSEC source: 0001415889-22-012736 · form4-12192022_101220.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,696 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Option NQ (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001415889-22-012075 · form4-12052022_091257.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 900 | $51.29 | $46,160.01 |
DisclosureSEC source: 0001415889-22-012075 · form4-12052022_091257.xml · nonDerivative · entry 3 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,348 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. F4 · price: The price reported in Column 4 is a weighted average price of $51.2889. The sold price range between $50.98 to $51.77. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,600 | $50.49 | $80,782.08 |
DisclosureSEC source: 0001415889-22-012075 · form4-12052022_091257.xml · nonDerivative · entry 2 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,248 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. F3 · price: The price reported in Column 4 is a weighted average price of $50.4888. The sold price range between $49.97 to $50.92. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,500 | $17.29 | $43,225.00 |
DisclosureSEC source: 0001415889-22-012075 · form4-12052022_091257.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. F2 · balance_after: The balance is adjusted to reflect 211 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/22. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 21:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 13,000 | $111.04 | $1,443,478.40 |
DisclosureSEC source: 0001415889-22-008829 · form4-08182022_020813.xml · nonDerivative · entry 2 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 302,049 F4 · price: The price reported in Column 4 is a weighted average price of $111.0368. The sold price range between $110.6 to $111.51. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| August 12, 2022 Filed Aug 18, 2022 21:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008829 · form4-08182022_020813.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 315,049 F1 · shares: Gift of 12,000 shares on 8/12/22 from Family Trust Account to Donor Advised Fund. F2 · balance_after: 41,925 shares transferred from directly owned account to Family Trust Account on 6/24/22. F3 · balance_after: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:15 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,728 | $113.11 | $987,224.08 |
DisclosureSEC source: 0001415889-22-006771 · form4-06172022_020603.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director · CHAIRMAN, PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,062 F1 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,939 | $131.21 | $385,626.19 |
DisclosureSEC source: 0001179110-22-002275 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,790 F4 · shares: Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 41,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002275 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,729 F3 · shares: Reflects performance-based restricted stock units that were previously granted on February 9, 2021 subject to the Company meeting certain stock performance objectives compared to the NASDAQ Healthcare Index, as previously reported at the target amount of 20,715 shares on Form 4 filed on February 11, 2021. On March 14, 2022 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 41,430 performance-based restricted stock units (200% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022. F3 · balance_after: Reflects performance-based restricted stock units that were previously granted on February 9, 2021 subject to the Company meeting certain stock performance objectives compared to the NASDAQ Healthcare Index, as previously reported at the target amount of 20,715 shares on Form 4 filed on February 11, 2021. On March 14, 2022 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 41,430 performance-based restricted stock units (200% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 23:33 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 23,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001406 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,014 F4 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 22:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-011067 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,564 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 9,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006763 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,327 F5 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 23:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002733 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,474 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 20,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001582 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,352 F4 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2022 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% or 150% Or 200% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 20,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001582 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,116 F3 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 17:54 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 10,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011968 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,880 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $27.20 | $0.00 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · derivative · entry 10 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · derivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 100 | $124.75 | $12,475.00 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · nonDerivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F7 · price: The price reported in Column 4 is the exact price of $124.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.